🔎 Trials Near Me

Home › Colorectal Cancer › Virginia › Roanoke

Pag-aaral pangklinika para sa Colorectal Cancer sa Roanoke, VA

Isang pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Roanoke. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Blue Ridge Cancer Care - Blacksburg /ID# 280115, Blacksburg · 26 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07525206

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Roanoke
  • Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Salem · 6 mi ang layo
  • Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg · 26 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Nagre-recruitPhase 1/2
  • Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06428409

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Nagre-recruitPhase 3
  • Blue Ridge Cancer Care - 300202915, Roanoke
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07549412

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • Oncology & Hematology Associates of Southwest Virginia, Roanoke
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT03526835

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Nagre-recruitPhase 3
  • Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care, Roanoke
  • Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Salem · 6 mi ang layo
  • Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Blacksburg · 26 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05253651

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Nagre-recruitPhase 2
  • Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA), Salem · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07011576

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • Carilion Roanoke Memorial Hospital, Roanoke
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT07018869

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Carilion Roanoke Memorial Hospital, Roanoke
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Pag-aaral para sa Colorectal Cancer sa ibang lungsod

Iba pang pag-aaral sa Roanoke

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.